Bevacizumab [bevacizumab]

topical
452
Terms

Avastin

 

Avastin
Bevacizumab-awwb
Mvasi

Persistent link   https://www.medvik.cz/link/D000068258
Definition

An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.

DUI
D000068258 MeSH Browser
CUI
M0443627
History note
2016 (2002)
Public note
2016; BEVACIZUMAB was indexed under ANTIBODIES, MONOCLONAL, HUMANIZED 2012-2015, and under ANTIBODIES, MONOCLONAL 2002-2011

Allowable subheadings

AD
administration & dosage 127
AE
adverse effects 71
AN
analysis 1
BI
biosynthesis
BL
blood
CF
cerebrospinal fluid
CH
chemistry
CL
classification
DE
drug effects 3
EC
economics 5
GE
genetics
HI
history
IM
immunology
IP
isolation & purification
ME
metabolism
PK
pharmacokinetics 17
PD
pharmacology 60
PH
physiology
PO
poisoning
RE
radiation effects
TU
therapeutic use 232
TO
toxicity 1
UL
ultrastructure
UR
urine

D Chemicals and Drugs
D12 Amino Acids, Peptides, and Proteins 16
D12.776 Proteins 2 581
D12.776.124 Blood Proteins 909
D12.776.124.486 Immunoproteins 14
D12.776.124.486.485 Immunoglobulins 1 492
D12.776.124.486.485.114 Antibodies 1 815
D12.776.124.486.485.114.224 Antibodies, Monoclonal 4 659
D12.776.124.486.485.114.224.060 Antibodies, Monoclonal, Humanized 2 854
D12.776.124.486.485.114.224.060.125 Abciximab 14
D12.776.124.486.485.114.224.060.250 Adalimumab 349
D12.776.124.486.485.114.224.060.313 Alemtuzumab 125
D12.776.124.486.485.114.224.060.344 Basiliximab 2
D12.776.124.486.485.114.224.060.375 Bevacizumab 452
D12.776.124.486.485.114.224.060.438 Brentuximab Vedotin 42
D12.776.124.486.485.114.224.060.500 Certolizumab Pegol 47
D12.776.124.486.485.114.224.060.750 Cetuximab 186
D12.776.124.486.485.114.224.060.766 Daclizumab 6
D12.776.124.486.485.114.224.060.782 Denosumab 153
D12.776.124.486.485.114.224.060.790 Gemtuzumab 16
D12.776.124.486.485.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.486.485.114.224.060.798 Ipilimumab 263
D12.776.124.486.485.114.224.060.813 Natalizumab 157
D12.776.124.486.485.114.224.060.829 Nivolumab 449
D12.776.124.486.485.114.224.060.844 Omalizumab 112
D12.776.124.486.485.114.224.060.860 Palivizumab 12
D12.776.124.486.485.114.224.060.864 Panitumumab 58
D12.776.124.486.485.114.224.060.866 Ramucirumab 1
D12.776.124.486.485.114.224.060.868 Ranibizumab 61
D12.776.124.486.485.114.224.060.875 Trastuzumab 274
D12.776.124.486.485.114.224.060.937 Ustekinumab 121
D12.776.124.790 Serum Globulins 61
D12.776.124.790.651 Immunoglobulins 1 492
D12.776.124.790.651.114 Antibodies 1 815
D12.776.124.790.651.114.224 Antibodies, Monoclonal 4 659
D12.776.124.790.651.114.224.060 Antibodies, Monoclonal, Humanized 2 854
D12.776.124.790.651.114.224.060.125 Abciximab 14
D12.776.124.790.651.114.224.060.250 Adalimumab 349
D12.776.124.790.651.114.224.060.375 Alemtuzumab 125
D12.776.124.790.651.114.224.060.407 Basiliximab 2
D12.776.124.790.651.114.224.060.438 Bevacizumab 452
D12.776.124.790.651.114.224.060.469 Brentuximab Vedotin 42
D12.776.124.790.651.114.224.060.500 Certolizumab Pegol 47
D12.776.124.790.651.114.224.060.750 Cetuximab 186
D12.776.124.790.651.114.224.060.766 Daclizumab 6
D12.776.124.790.651.114.224.060.782 Denosumab 153
D12.776.124.790.651.114.224.060.790 Gemtuzumab 16
D12.776.124.790.651.114.224.060.794 Inotuzumab Ozogamicin 12
D12.776.124.790.651.114.224.060.798 Ipilimumab 263
D12.776.124.790.651.114.224.060.813 Natalizumab 157
D12.776.124.790.651.114.224.060.829 Nivolumab 449
D12.776.124.790.651.114.224.060.844 Omalizumab 112
D12.776.124.790.651.114.224.060.860 Palivizumab 12
D12.776.124.790.651.114.224.060.864 Panitumumab 58
D12.776.124.790.651.114.224.060.866 Ramucirumab 1
D12.776.124.790.651.114.224.060.868 Ranibizumab 61
D12.776.124.790.651.114.224.060.875 Trastuzumab 274
D12.776.124.790.651.114.224.060.937 Ustekinumab 121
D12.776.377 Globulins 68
D12.776.377.715 Serum Globulins 61
D12.776.377.715.548 Immunoglobulins 1 492
D12.776.377.715.548.114 Antibodies 1 815
D12.776.377.715.548.114.224 Antibodies, Monoclonal 4 659
D12.776.377.715.548.114.224.200 Antibodies, Monoclonal, Humanized 2 854
D12.776.377.715.548.114.224.200.125 Abciximab 14
D12.776.377.715.548.114.224.200.250 Adalimumab 349
D12.776.377.715.548.114.224.200.375 Alemtuzumab 125
D12.776.377.715.548.114.224.200.407 Basiliximab 2
D12.776.377.715.548.114.224.200.438 Bevacizumab 452
D12.776.377.715.548.114.224.200.469 Brentuximab Vedotin 42
D12.776.377.715.548.114.224.200.500 Certolizumab Pegol 47
D12.776.377.715.548.114.224.200.750 Cetuximab 186
D12.776.377.715.548.114.224.200.766 Daclizumab 6
D12.776.377.715.548.114.224.200.782 Denosumab 153
D12.776.377.715.548.114.224.200.790 Gemtuzumab 16
D12.776.377.715.548.114.224.200.794 Inotuzumab Ozogamicin 12
D12.776.377.715.548.114.224.200.798 Ipilimumab 263
D12.776.377.715.548.114.224.200.813 Natalizumab 157
D12.776.377.715.548.114.224.200.829 Nivolumab 449
D12.776.377.715.548.114.224.200.844 Omalizumab 112
D12.776.377.715.548.114.224.200.860 Palivizumab 12
D12.776.377.715.548.114.224.200.864 Panitumumab 58
D12.776.377.715.548.114.224.200.866 Ramucirumab 1
D12.776.377.715.548.114.224.200.868 Ranibizumab 61
D12.776.377.715.548.114.224.200.875 Trastuzumab 274
D12.776.377.715.548.114.224.200.937 Ustekinumab 121

89Zr-bevacizumab Chemical MeSH Browser

BEVZ92 Chemical MeSH Browser

technetium 99m tricarbonyl bevacizumab Chemical MeSH Browser

Back Add